PGIM Jennison Health Sciences Fund- Class C
PHLCX
NASDAQ
| Weiss Ratings | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | PGIM | |||
| Manager/Tenure (Years) | Debra Netschert (11), Daniel Matviyenko (5) | |||
| Website | http://pgim.com/investments | |||
| Fund Information | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | PGIM Jennison Health Sciences Fund- Class C | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jun 30, 1999 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 100.00 | |||
| Front End Fee | -- | |||
| Back End Fee | 0.01 | |||
| Dividends and Shares | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.15% | |||
| Dividend | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.67% | |||
| Asset Allocation | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 7.14% | |||
| Stock | 92.86% | |||
| U.S. Stock | 86.10% | |||
| Non-U.S. Stock | 6.76% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.43% | |||
| 30-Day Total Return | -4.05% | |||
| 60-Day Total Return | -0.09% | |||
| 90-Day Total Return | -0.95% | |||
| Year to Date Total Return | 6.44% | |||
| 1-Year Total Return | 23.96% | |||
| 2-Year Total Return | 16.70% | |||
| 3-Year Total Return | 49.30% | |||
| 5-Year Total Return | 37.10% | |||
| Price | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $10.40 | |||
| 1-Month Low NAV | $10.39 | |||
| 1-Month High NAV | $10.93 | |||
| 52-Week Low NAV | $8.82 | |||
| 52-Week Low NAV (Date) | Mar 27, 2026 | |||
| 52-Week High NAV | $15.17 | |||
| 52-Week High Price (Date) | Nov 26, 2025 | |||
| Beta / Standard Deviation | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.58 | |||
| Standard Deviation | 15.52 | |||
| Balance Sheet | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.50B | |||
| Operating Ratios | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.97% | |||
| Turnover Ratio | 81.00% | |||
| Performance | PHLCX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 23.20% | |||
| Last Bear Market Total Return | -9.62% | |||